Karlsson MO - Search Results

1

Development and comparison of model-integrated evidence approaches for bioequivalence studies with pharmacokinetic end points.

Chen X, Nyberg HB, Donnelly M, Zhao L, Fang L, Karlsson MO, Hooker AC. Chen X, et al. Among authors: karlsson mo. CPT Pharmacometrics Syst Pharmacol. 2024 Oct;13(10):1734-1747. doi: 10.1002/psp4.13216. Epub 2024 Aug 23. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 39177211 Free PMC article.

2

Conditional weighted residuals (CWRES): a model diagnostic for the FOCE method.

Hooker AC, Staatz CE, Karlsson MO. Hooker AC, et al. Among authors: karlsson mo. Pharm Res. 2007 Dec;24(12):2187-97. doi: 10.1007/s11095-007-9361-x. Epub 2007 Jul 6. Pharm Res. 2007. PMID: 17612795

3

Population pharmacokinetic model for docetaxel in patients with varying degrees of liver function: incorporating cytochrome P4503A activity measurements.

Hooker AC, Ten Tije AJ, Carducci MA, Weber J, Garrett-Mayer E, Gelderblom H, McGuire WP, Verweij J, Karlsson MO, Baker SD. Hooker AC, et al. Among authors: karlsson mo. Clin Pharmacol Ther. 2008 Jul;84(1):111-8. doi: 10.1038/sj.clpt.6100476. Epub 2008 Jan 9. Clin Pharmacol Ther. 2008. PMID: 18183036 Free PMC article.

4

Trial treatment length optimization with an emphasis on disease progression studies.

Hennig S, Nyberg J, Hooker AC, Karlsson MO. Hennig S, et al. Among authors: karlsson mo. J Clin Pharmacol. 2009 Mar;49(3):323-35. doi: 10.1177/0091270008329560. J Clin Pharmacol. 2009. PMID: 19246730

5

Modeling subpopulations with the $MIXTURE subroutine in NONMEM: finding the individual probability of belonging to a subpopulation for the use in model analysis and improved decision making.

Carlsson KC, Savić RM, Hooker AC, Karlsson MO. Carlsson KC, et al. Among authors: karlsson mo. AAPS J. 2009 Mar;11(1):148-54. doi: 10.1208/s12248-009-9093-4. Epub 2009 Mar 10. AAPS J. 2009. PMID: 19277871 Free PMC article.

6

Simultaneous optimal experimental design on dose and sample times.

Nyberg J, Karlsson MO, Hooker AC. Nyberg J, et al. Among authors: karlsson mo. J Pharmacokinet Pharmacodyn. 2009 Apr;36(2):125-45. doi: 10.1007/s10928-009-9114-z. Epub 2009 Mar 25. J Pharmacokinet Pharmacodyn. 2009. PMID: 19319484

7

Optimization of the intravenous glucose tolerance test in T2DM patients using optimal experimental design.

Silber HE, Nyberg J, Hooker AC, Karlsson MO. Silber HE, et al. Among authors: karlsson mo. J Pharmacokinet Pharmacodyn. 2009 Jun;36(3):281-95. doi: 10.1007/s10928-009-9123-y. Epub 2009 Jun 25. J Pharmacokinet Pharmacodyn. 2009. PMID: 19554431

8

Methodological comparison of in vitro binding parameter estimation: sequential vs. simultaneous non-linear regression.

Ernest CS 2nd, Hooker AC, Karlsson MO. Ernest CS 2nd, et al. Among authors: karlsson mo. Pharm Res. 2010 May;27(5):866-77. doi: 10.1007/s11095-010-0082-1. Epub 2010 Mar 11. Pharm Res. 2010. PMID: 20221897

9

Ethically attractive dose-finding designs for drugs with a narrow therapeutic index.

Lledó-García R, Hennig S, Nyberg J, Hooker AC, Karlsson MO. Lledó-García R, et al. Among authors: karlsson mo. J Clin Pharmacol. 2012 Jan;52(1):29-38. doi: 10.1177/0091270010390041. Epub 2011 Jan 12. J Clin Pharmacol. 2012. PMID: 21228403

10

Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models.

Bergstrand M, Hooker AC, Wallin JE, Karlsson MO. Bergstrand M, et al. Among authors: karlsson mo. AAPS J. 2011 Jun;13(2):143-51. doi: 10.1208/s12248-011-9255-z. Epub 2011 Feb 8. AAPS J. 2011. PMID: 21302010 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

435 results

Search Page

Filters